Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology

Cancer is classically considered a disease of aging, with over half of all new cancer diagnoses occurring in patients over the age of 65 years. Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, yet the participation of older adults with cancer in ICI trials has been suboptima...

Descripción completa

Detalles Bibliográficos
Autores principales: Choucair, Khalil, Naqash, Abdul Rafeh, Nebhan, Caroline A, Nipp, Ryan, Johnson, Douglas B, Saeed, Anwaar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Immuno-Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438919/
https://www.ncbi.nlm.nih.gov/pubmed/35781739
http://dx.doi.org/10.1093/oncolo/oyac119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9438919/
https://www.ncbi.nlm.nih.gov/pubmed/35781739
http://dx.doi.org/10.1093/oncolo/oyac119

Ejemplares similares